Canlyniadau Chwilio - Urbschat, Steffi

Deletions in the 17q chromosomal region and their influence on the clonal cytogenetic evolution of recurrent meningiomas gan Hemmer, Sina, Urbschat, Steffi, Oertel, Joachim, Ketter, Ralf

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Confocal Laser Endomicroscopy in Neurosurgery: A New Technique with Much Potential gan Breuskin, David, DiVincenzo, Jana, Kim, Yoo-Jin, Urbschat, Steffi, Oertel, Joachim

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Establishment of a molecular cytogenetic analysis for native tumor tissue of meningiomas-suitable for clinical application gan Lerner, Cornelia, Ketter, Ralf, Linsler, Stefan, Henn, Wolfram, Oertel, Joachim, Urbschat, Steffi

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Importance of biomarkers in glioblastomas patients receiving local BCNU wafer chemotherapy gan Urbschat, Steffi, Sippl, Christoph, Engelhardt, Jana, Kammers, Kai, Oertel, Joachim, Ketter, Ralf

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Promoter methylation of RB1, P15, P16, and MGMT and their impact on the clinical course of pilocytic astrocytomas gan Sippl, Christoph, Urbschat, Steffi, Kim, Yoo Jin, Senger, Sebastian, Oertel, Joachim, Ketter, Ralf

Cael y testun llawn Cael y testun llawn Cael y testun llawn

CSIG-14. PROTEIN KINASE CK2 REGULATES THE EXPRESSION OF NERVE/GLIAL ANTIGEN (NG)2 IN GLIOBLASTOMA gan Schmitt, Beate, Sippl, Christoph, Urbschat, Steffi, Oertel, Joachim, Laschke, Matthias, Menger, Michael, Ampofo, Emmanuel

Cael y testun llawn Cael y testun llawn

Molecular Biological Determinations of Meningioma Progression and Recurrence gan Linsler, Stefan, Kraemer, Dennis, Driess, Christina, Oertel, Joachim, Kammers, Kai, Rahnenführer, Jörg, Ketter, Ralf, Urbschat, Steffi

Cael y testun llawn Cael y testun llawn Cael y testun llawn

CSIG-18. NERVE/GLIAL ANTIGEN (NG)2 EXPRESSION IN GLIOBLASTOMA IS REGULATED BY miR-29b-3p gan Schmitt, Beate, Boewe, Anne, Gu, Yuan, Sippl, Christoph, Urbschat, Steffi, Oertel, Joachim, Laschke, Matthias, Menger, Michael, Ampofo, Emmanuel

Cael y testun llawn Cael y testun llawn

CK2 Activity Mediates the Aggressive Molecular Signature of Glioblastoma Multiforme by Inducing Nerve/Glial Antigen (NG)2 Expression gan Schmitt, Beate M., Boewe, Anne S., Götz, Claudia, Philipp, Stephan E., Urbschat, Steffi, Oertel, Joachim, Menger, Michael D., Laschke, Matthias W., Ampofo, Emmanuel

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Bisulfite profiling of the MGMT promoter and comparison with routine testing in glioblastoma diagnostics gan Tierling, Sascha, Jürgens-Wemheuer, Wiebke M., Leismann, Alea, Becker-Kettern, Julia, Scherer, Michael, Wrede, Arne, Breuskin, David, Urbschat, Steffi, Sippl, Christoph, Oertel, Joachim, Schulz-Schaeffer, Walter J., Walter, Jörn

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Patients with High-Grade Gliomas Harboring Deletions of Chromosomes 9p and 10q Benefit from Temozolomide Treatment gan Wemmert, Silke, Ketter, Ralf, Rahnenführer, Jörg, Beerenwinkel, Niko, Strowitzki, Martin, Feiden, Wolfgang, Hartmann, Christian, Lengauer, Thomas, Stockhammer, Florian, Zang, Klaus D, Meese, Eckart, Steudel, Wolf-Ingo, von Deimling, Andreas, Urbschat, Steffi

Cael y testun llawn Cael y testun llawn

Transcriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO grade gan Schmidt, Melissa, Mock, Andreas, Jungk, Christine, Sahm, Felix, Ull, Anna Theresa, Warta, Rolf, Lamszus, Katrin, Gousias, Konstantinos, Ketter, Ralf, Roesch, Saskia, Rapp, Carmen, Schefzyk, Sebastian, Urbschat, Steffi, Lahrmann, Bernd, Kessler, Almuth F., Löhr, Mario, Senft, Christian, Grabe, Niels, Reuss, David, Beckhove, Philipp, Westphal, Manfred, von Deimling, Andreas, Unterberg, Andreas, Simon, Matthias, Herold-Mende, Christel

Cael y testun llawn Cael y testun llawn Cael y testun llawn